Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib Maintenance in Metastatic Colorectal Carcinoma
NCT01483638Phase 2Terminated
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Feb 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in colorectal cancer (CRC), sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Feb 2012; status: terminated.
02
Drugs
axitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01483638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01483638.